Assessing importance of biomarkers: A Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks
From MaRDI portal
Publication:3389290
Recommendations
- Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data
- Bayesian estimation of two‐part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation
- A Bayesian semiparametric survival model with longitudinal markers
- Identification of longitudinal biomarkers in survival analysis for competing risks data
- A flexible joint model for multiple longitudinal biomarkers and a time‐to‐event outcome: With applications to dynamic prediction using highly correlated biomarkers
- Bayesian semiparametric analysis of short- and long-term hazard ratios with covariates
- A Bayesian method to estimate the optimal threshold of a longitudinal biomarker
- Semiparametric Bayesian joint models of multivariate longitudinal and survival data
- A Semiparametric Bayesian Approach for the Analysis of Competing Risks Data
- Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data
Cites work
- scientific article; zbMATH DE number 2222300 (Why is no real title available?)
- A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival
- A Joint Model for Longitudinal Measurements and Survival Data in the Presence of Multiple Failure Types
- A New Bayesian Model for Survival Data with a Surviving Fraction
- A Predictive Approach to Model Selection
- A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects
- A new joint model for longitudinal and survival data with a cure fraction
- Assessing the association between trends in a biomarker and risk of event with an application in pediatric HIV/AIDS
- Bayesian Measures of Model Complexity and Fit
- Bayesian approaches to joint cure-rate and longitudinal models with applications to cancer vaccine trials
- Bayesian approaches to joint longitudinal and survival models accommodating both zero and nonzero cure fractions
- Estimation of treatment effects and model diagnostics with two-way time-varying treatment switching: an application to a head and neck study
- Generating random correlation matrices based on vines and extended onion method
- Joint Analysis of Longitudinal Data Comprising Repeated Measures and Times to Events
- Joint Models for Multivariate Longitudinal and Multivariate Survival Data
- Joint models for longitudinal and time-to-event data. With applications in R
- Missing responses in generalized linear mixed models when the missing data mechanism is nonintegrable
- Modeling Disease Market Processes in AIDS
- Modelling Progression of CD4-Lymphocyte Count and Its Relationship to Survival Time
- Monte Carlo methods in Bayesian computation
- Score test for conditional independence between longitudinal outcome and time to event given the classes in the joint latent class model
- Semiparametric Modeling of Longitudinal Measurements and Time‐to‐Event Data–A Two‐Stage Regression Calibration Approach
- The Evaluation of Multiple Surrogate Endpoints
- The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure
Cited in
(4)- Bayesian model assessment for jointly modeling multidimensional response data with application to computerized testing
- New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes
- Bayesian criterion-based assessments of recurrent event models with applications to commercial truck driver behavior studies
- Joint analysis of longitudinal measurements and spatially clustered competing risks HIV/AIDS data
This page was built for publication: Assessing importance of biomarkers: A Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3389290)
